SPEAKER
(S):
Tony Clement, Minister of Health, Government of Canada
Michael Morgan, Chief Science Officer, Genome Canada
Thomas J. Hudson, MD, President and Scientific Director, Ontario Institute for Cancer Research
Mark Lievonen, President, sanofi pasteur Ltd
Philippe Calais, President, Global Business, Neurochem Inc
Description
With its first-rate research infrastructure, dynamic and globally oriented biotechnology firms, world-class innovative scientists, and supportive investment climate, Canada offers unparalleled opportunities for strategic partnerships and research collaborations, clinical trials, and R&D and manufacturing.
Objectives:
Learn about Canada's research excellence from Canada's leading health innovators.
Hear first-hand accounts of Canada's advantages from firms operating in Canada.
Find out why Canada is a great place to invest, partner and grow your business.